About SS-31 (Elamipretide)
SS-31 (Elamipretide) is a mitochondria-targeted aromatic-cationic tetrapeptide studied in research investigating mitochondrial function, oxidative stress markers, cardiolipin interactions, and cellular bioenergetics. Supplied as a lyophilized powder for laboratory use. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury.
Recent research on SS-31 (Elamipretide): Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury.
Read Full Study on PubMedTherapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function.
Recent research on SS-31 (Elamipretide): Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function.
Read Full Study on PubMedAdditional Studies
Mechanisms of Anti-Oxidants, N-Acetylcysteine and Elamipretide (SS-31), on Ozone-Induced Airway Hyperresponsiveness and Mucus Hypersecretion.
Recent research on SS-31 (Elamipretide): Mechanisms of Anti-Oxidants, N-Acetylcysteine and Elamipretide (SS-31), on Ozone-Induced Airway Hyperresponsiveness and Mucus Hypersecretion.
Read on PubMedSS-31 improves post-cardiac arrest brain injury by inhibiting microglial ferroptosis and polarization.
Recent research on SS-31 (Elamipretide): SS-31 improves post-cardiac arrest brain injury by inhibiting microglial ferroptosis and polarization.
Read on PubMedTherapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury.
Recent research on SS-31 (Elamipretide): Therapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury.
Read on PubMedEndothelial Glycocalyx Degradation as a Mediator of Neuroinflammation and Cognitive Impairment in Aged Rats: Protective Role of SS-31.
Recent research on SS-31 (Elamipretide): Endothelial Glycocalyx Degradation as a Mediator of Neuroinflammation and Cognitive Impairment in Aged Rats: Protective Role of SS-31.
Read on PubMedMitochondrial dysfunction drives age-related degeneration of the thoracic aorta.
Recent research on SS-31 (Elamipretide): Mitochondrial dysfunction drives age-related degeneration of the thoracic aorta.
Read on PubMedEnvironmental enrichment highlights mitochondrial inner membrane function as a therapeutic target for sepsis-associated encephalopathy.
Recent research on SS-31 (Elamipretide): Environmental enrichment highlights mitochondrial inner membrane function as a therapeutic target for sepsis-associated encephalopathy.
Read on PubMedRelated Research
Purchase SS-31 (Elamipretide) from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.